NCT01433380View on ClinicalTrials.gov

A Study To Evaluate PF-05175157 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

PF-05175157

One single dose of PF-05175157 will be administered as a powder-in-capsule in the fasting state in the AM.

DRUG

Placebo

One single dose of placebo will be administered as a powder-in-capsule in the fasting state in the AM.

Trial Locations (1)

70808

Pfizer Investigational Site, Baton Rouge

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01433380 - A Study To Evaluate PF-05175157 In Healthy Volunteers | Biotech Hunter | Biotech Hunter